Multidetector-row computed tomography findings of sclerosing mesenteritis with associated diseases and its prevalence
- PMID: 21882092
- DOI: 10.1007/s11604-011-0587-5
Multidetector-row computed tomography findings of sclerosing mesenteritis with associated diseases and its prevalence
Abstract
Purpose: Our aim was to report the multidetector-row computed tomography (MDCT) findings of sclerosing mesenteritis, which is a rare disease characterized by chronic nonspecific inflammation of mesenteric adipose tissue. It has associated diseases, and we explored its prevalence.
Materials and methods: A total of 2100 patients were evaluated retrospectively for sclerosing mesenteritis between December 2007 and May 2009. Signs and symptoms, associated diseases, laboratory data, surgical histories, and related findings of a misty mesentery, which corresponds to sclerosing mesenteritis on MDCT, were recorded.
Results: Misty mesentery findings were seen in 51 (2.43%; 35 men) patients. Their ages ranged between 33 and 78 years (mean 56.2 years). The most frequent complaint of patients was abdominal pain (n = 19; 37.2%). The most prominent possible causative and/or associated factors in our study were malignancy (n = 9; 17.6%), previous surgery (n = 17; 33.3%), smoking (n = 20; 39.2%), coronary artery disease (n = 9; 17.6%), urolithiasis (n = 10; 19.6%), hypertension (n = 18; 35.2%), hyperlipidemia (n = 13; 25.5%), and diabetes mellitus (n = 11; 21.5%). On MDCT, density values in mesenteric fat (-62.8 ± 18.6 HU) were significantly higher than the values for subcutaneous (-103.9 ± 5.8 HU) and retroperitoneal (-105 ± 6 HU) fatty tissues (both P < 0.0001). A partially hyperdense stripe (n = 37; 72.6%), well-defined soft tissue nodules (100%), hypodense fatty halo enclosing vessels (n = 1; 1.9%), and nodules (n = 12; 23.5%) were demonstrated in most of the patients.
Conclusion: The diagnosis of sclerosing mesenteritis has increased with the more frequent use of MDCT and the popularization of the DICOM viewer. Defined hallmarks on MDCT can be helpful for differentiating sclerosing mesenteritis from other pathologies.
Similar articles
-
Mesenteric panniculitis. Part 1: MDCT--pictorial review.JBR-BTR. 2011 Sep-Oct;94(5):229-40. doi: 10.5334/jbr-btr.658. JBR-BTR. 2011. PMID: 22191287
-
CT findings in sclerosing mesenteritis (panniculitis): spectrum of disease.Radiographics. 2003 Nov-Dec;23(6):1561-7. doi: 10.1148/rg.1103035010. Radiographics. 2003. PMID: 14615565 Review.
-
Sclerosing mesenteritis.Australas Radiol. 2005 Apr;49(2):185-8. doi: 10.1111/j.1440-1673.2005.01400.x. Australas Radiol. 2005. PMID: 15845064
-
MR findings in a rare case of sclerosing mesenteritis of the mesocolon.J Magn Reson Imaging. 2005 May;21(5):632-6. doi: 10.1002/jmri.20280. J Magn Reson Imaging. 2005. PMID: 15834906
-
Misty mesentery: a pictorial review of multidetector-row CT findings.Radiol Med. 2011 Apr;116(3):351-65. doi: 10.1007/s11547-010-0610-4. Epub 2010 Dec 3. Radiol Med. 2011. PMID: 21311992 Review. English, Italian.
Cited by
-
A Single Tertiary Center 14-year Experience With Mesenteric Panniculitis in Turkey: A Retrospective Study of 716 Patients.Turk J Gastroenterol. 2023 Feb;34(2):140-147. doi: 10.5152/tjg.2023.22514. Turk J Gastroenterol. 2023. PMID: 36843301 Free PMC article.
-
Mesenteric panniculitis: systematic review of cross-sectional imaging findings and risk of subsequent malignancy.Eur Radiol. 2016 Dec;26(12):4531-4537. doi: 10.1007/s00330-016-4298-2. Epub 2016 Apr 5. Eur Radiol. 2016. PMID: 27048526 Free PMC article.
-
The Complex Relationship between Mesenteric Panniculitis and Malignancy - A Holistic Approach is Still Needed to Understand the Diagnostic Uncertainties.Cureus. 2019 Sep 5;11(9):e5569. doi: 10.7759/cureus.5569. Cureus. 2019. PMID: 31695988 Free PMC article. Review.
-
The Use of Glucocorticoids for Better Control of Diabetes Mellitus: The Paradox of Sclerosing Mesenteritis (The Rare Could Become Common).Am J Case Rep. 2021 May 31;22:e930453. doi: 10.12659/AJCR.930453. Am J Case Rep. 2021. PMID: 34054123 Free PMC article.
-
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma.Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1330-6. doi: 10.1007/s00259-013-2429-4. Epub 2013 May 8. Eur J Nucl Med Mol Imaging. 2013. PMID: 23653244
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources